The Recombinant Humanized Anti-TIGIT Monoclonal Antibody (JS006) Monotherapy and in Combination With Toripalimab in Patients With Advanced Tumor
Clinical trial NCT05061628 · COMPLETED
Trial details
- NCT number
- NCT05061628
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-21
- Primary completion
- 2023-04-23
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.